Search

By Industry Solutions (2)
By Phase (1)
By Molecule Type (1)
By Therapeutic Area (3)
Covance Events (9)
Geography (3)
Keywords (10)

Filters

Showing results 881 - 896 of 91813 for .

Showing results 881 - 896 of 91813 for .

Analysis of Proximate and Minerals Certificate (Battle Creek, MI)
Recognition of Analytical Performance - Analysis of Proximate and Minerals Certificate (Battle Creek, MI)
Analysis of SugarCertificate (Battle Creek, WI)
Recognition of Analytical Performance - Analysis of SugarCertificate
Analysis of Mineral Certificate (Battle Creek, MI)
Recognition of Analytical Performance - Analysis of Mineral Certificate (Battle Creek, MI)
A2LA Accredited Biological Testing Laboratory (Battle Creek, WI)
Scope of Accreditation to ISO/IEC 17025:2005 (Battle Creek, WI)
A2LA Accredited Chemical Testing Laboratory (Battle Creek, MI)
Scope of Accreditation to ISO/IEC 17025:2005 (Battle Creek, MI)
A2LA Accredited Chemical Testing Laboratory (Greenfield, IN)
Scope of Accreditation to ISO/IEC 17025:2005 (Greenfield, IN)
Certificate of Accreditation in Residue Chemistry (Greenfield, IN)
Certificate of Accreditation in Residue Chemistry for analysis of Chlorinated Hydrocarbons (Greenfield, IN)
A2LA Accredited Biological Testing Laboratory (Madison WI)
Scope of Accreditation to ISO/IEC 17025:2005 (Madison WI)
A2LA Accredited Chemical Testing Laboratory (Madison, WI)
Scope of Accreditation to ISO/IEC 17025:2005 (Madison, WI)
Certificate of Accreditation in Food Chemistry (Madison, WI)
Certificate of Accreditation in Food Chemistry for analysis of Moisture, Protein, Fat and Salt in Meat and Poultry Products (Madison, WI)
A2LA Accredited Chemical Testing Laboratory (Singapore)
Scope of Accreditation to ISO/IEC 17025:2005 (Singapore)
Microbiology Consulting Newsletter Issue 1
Microbiology Consulting Newsletter Issue 1
Use of Miniaturized Bacterial Mutagenicity Assays for Drug Candidate Screening and Impurity Evaluation
SOT 2017 - Mutagenicity evaluation is required by regulatory agencies prior to first in human trials and/or pharmaceutical marketing. Early screening of drug candidates for mutagenic potential is beneficial to reduce mutagenicity-related late stage attrition and maximize hazard identification while minimizing resource expenditure. The 6- and 24-well plate Ames assays require significantly less amount of test article and are similar to the plate incorporation method using full plates. The...
Using Liquid Biopsies and NGS as Tools to Analyze Mutation Burden and Copy Number Variation in the Blood of a Patient with Triple Negative Breast Cancer to Better Inform Therapeutic Targets
AACR 2017 -- The ability to characterize molecular features of cancer from liquid biopsies is resulting in the development of innovative health care for patients. Longitudinal changes in the mutational profiles of DNA isolated from liquid biopsies are being used to better understand and monitor the development, progression, and evolution of therapy resistance in cancer patients.
A Cross Comparison of Technologies for the Detection of Immune System Related Gene Expression Signatures in Clinical FFPE Samples of Metastatic Prostate Cancer Patients
AACR 2017 -- The success of immunotherapy for the treatment of metastatic cancers relies on the prediction and identification of potential neo-antigens. In recent years, expression levels of these neo-antigens along with other immune system related genes have been evaluated in an effort to better understand response rates for immunotherapy in various cancers. Gene expression levels can be assessed by numerous techniques including hybridization-based or direct sequencing technologies.